PL1890680T3 - Formulacje diklofenaku i sposoby użycia - Google Patents
Formulacje diklofenaku i sposoby użyciaInfo
- Publication number
- PL1890680T3 PL1890680T3 PL06743167T PL06743167T PL1890680T3 PL 1890680 T3 PL1890680 T3 PL 1890680T3 PL 06743167 T PL06743167 T PL 06743167T PL 06743167 T PL06743167 T PL 06743167T PL 1890680 T3 PL1890680 T3 PL 1890680T3
- Authority
- PL
- Poland
- Prior art keywords
- methods
- diclofenac formulations
- diclofenac
- formulations
- Prior art date
Links
- DCOPUUMXTXDBNB-UHFFFAOYSA-N diclofenac Chemical compound OC(=O)CC1=CC=CC=C1NC1=C(Cl)C=CC=C1Cl DCOPUUMXTXDBNB-UHFFFAOYSA-N 0.000 title 1
- 229960001259 diclofenac Drugs 0.000 title 1
- 238000009472 formulation Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/196—Carboxylic acids, e.g. valproic acid having an amino group the amino group being directly attached to a ring, e.g. anthranilic acid, mefenamic acid, diclofenac, chlorambucil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
- A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1617—Organic compounds, e.g. phospholipids, fats
- A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Pain & Pain Management (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Neurology (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Biomedical Technology (AREA)
- Inorganic Chemistry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US69175705P | 2005-06-17 | 2005-06-17 | |
| US69202405P | 2005-06-17 | 2005-06-17 | |
| EP06743167.6A EP1890680B1 (en) | 2005-06-17 | 2006-06-16 | Diclofenac formulations and methods of use |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PL1890680T3 true PL1890680T3 (pl) | 2017-08-31 |
Family
ID=37396065
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PL06743167T PL1890680T3 (pl) | 2005-06-17 | 2006-06-16 | Formulacje diklofenaku i sposoby użycia |
Country Status (24)
| Country | Link |
|---|---|
| US (7) | US7759394B2 (pl) |
| EP (4) | EP1890680B1 (pl) |
| KR (1) | KR101352130B1 (pl) |
| CN (3) | CN112755014A (pl) |
| AR (1) | AR057378A1 (pl) |
| AU (1) | AU2006257072B2 (pl) |
| BR (1) | BRPI0612245A2 (pl) |
| CA (2) | CA2932603C (pl) |
| EC (1) | ECSP077989A (pl) |
| ES (3) | ES2717879T3 (pl) |
| GT (1) | GT200600261A (pl) |
| HK (1) | HK1213814A1 (pl) |
| JO (1) | JO3352B1 (pl) |
| MX (1) | MX2007016072A (pl) |
| NO (1) | NO342336B1 (pl) |
| NZ (1) | NZ564002A (pl) |
| PE (1) | PE20070074A1 (pl) |
| PL (1) | PL1890680T3 (pl) |
| PT (1) | PT1890680T (pl) |
| RU (1) | RU2432160C2 (pl) |
| TR (1) | TR201706038T4 (pl) |
| TW (1) | TW200740470A (pl) |
| WO (1) | WO2006133954A2 (pl) |
| ZA (1) | ZA200710858B (pl) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6974595B1 (en) * | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
| JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
| US7700125B2 (en) * | 2006-02-07 | 2010-04-20 | Kowa Pharmaceuticals America, Inc. | Moisture resistant container systems for rapidly bioavailable dosage forms |
| AU2008253125B2 (en) * | 2007-05-24 | 2013-11-07 | Novartis Ag | Oral dosage form providing fast absorption of drug |
| SG175315A1 (en) | 2009-04-24 | 2011-11-28 | Iceutica Pty Ltd | A novel formulation of indomethacin |
| MX347290B (es) * | 2009-04-24 | 2017-04-17 | Iceutica Pty Ltd | Una formulacion novedosa de diclofenaco. |
| WO2011036114A1 (en) * | 2009-09-25 | 2011-03-31 | Novartis Ag | Oral pharmaceutical composition comprising diclofenac |
| FR2984165B1 (fr) * | 2011-12-16 | 2014-06-27 | Pharmeuro | Traitement des crises de migraines, notamment d'algies vasculaires de la face |
| US9526734B2 (en) | 2014-06-09 | 2016-12-27 | Iceutica Pty Ltd. | Formulation of meloxicam |
| US9855234B2 (en) | 2014-07-08 | 2018-01-02 | Insys Development Company, Inc. | Diclofenac sublingual spray |
| CN106580886A (zh) * | 2016-12-05 | 2017-04-26 | 北京万全德众医药生物技术有限公司 | 一种双氯芬酸钾散剂及其制备方法 |
| WO2019030773A1 (en) * | 2017-08-10 | 2019-02-14 | Sarudbhava Formulations Private Limited | DICLOFENAC COMPOSITIONS WITH LOW DOSE |
| US11260026B2 (en) | 2018-12-14 | 2022-03-01 | Apr Applied Pharma Research Sa | Ready to use diclofenac stick packs |
| BR112022025132A2 (pt) | 2020-06-10 | 2022-12-27 | Applied Pharma Res | Formulações de diclofenaco à base de açúcar biodisponíveis |
| EP3928766A1 (en) | 2020-06-26 | 2021-12-29 | Usso Barnas | Pharmaceutical composition and use thereof |
| US20220241230A1 (en) * | 2021-02-03 | 2022-08-04 | Patrin Pharma, Inc. | Diclofenac sachet composition |
| CN115317464B (zh) * | 2022-09-01 | 2023-08-08 | 苏州弘森药业股份有限公司 | 一种双氯芬酸钾微胶囊及其制备方法 |
| GB2634218A (en) * | 2023-09-29 | 2025-04-09 | Approved Pharma Solutions Ltd | Powder for oral solution formulations |
| GB202401873D0 (en) * | 2024-02-12 | 2024-03-27 | Hawkins John | Lipophilic drug suspensions |
Family Cites Families (36)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3558690A (en) | 1965-04-08 | 1971-01-26 | Gelgy Chemical Corp | Substituted derivatives of 2-anilinophenylacetic acids and a process of preparation |
| US4344929A (en) * | 1980-04-25 | 1982-08-17 | Alza Corporation | Method of delivering drug with aid of effervescent activity generated in environment of use |
| JPS57191962A (en) | 1981-05-20 | 1982-11-25 | Hitachi Ltd | Fuel cell |
| IT1209667B (it) | 1985-11-12 | 1989-08-30 | Zambon Spa | Composizione effeverscente adattivita' analgesica. |
| CH673395A5 (pl) * | 1987-01-30 | 1990-03-15 | Ciba Geigy Ag | |
| US5211957A (en) * | 1988-03-25 | 1993-05-18 | Ciba-Geigy Corporation | Solid rapidly disintegrating dosage form |
| IT1226549B (it) | 1988-07-12 | 1991-01-24 | Resa Farma | Composizioni farmaceutiche ad attivita' analgesica ed antiinfiammatoria per uso orale, dotate di ottima palatabilita' ed esenti da effetti irritanti sulle mucose. |
| GB8824392D0 (en) | 1988-10-18 | 1988-11-23 | Ciba Geigy Ag | Dispersible formulation |
| GB8920693D0 (en) | 1989-09-13 | 1989-10-25 | Nicholas Kiwi Pty Ltd | Non-effervescent ibuprofen compositions |
| EP0466640B1 (de) | 1990-06-28 | 1995-05-24 | Ciba-Geigy Ag | Alpha-Carbonylphenylacetonitrilderivate als Stabilisatoren für organische Materialien |
| EP0466650A2 (en) | 1990-07-11 | 1992-01-15 | Warner-Lambert Company | Improvements in non-steroidal anti-inflammatory therapy |
| MX9300110A (es) * | 1992-01-13 | 1994-07-29 | Gerhard Gergely | Preparacion farmaceutica en la forma de una tableta de efervescencia o de desintegracion o de un granulado de tipo instanteneo y procedimiento para su preparacion. |
| CA2141582C (en) * | 1992-08-05 | 2003-09-30 | Angelo Mario Morella | Pelletised pharmaceutical composition |
| IT1264696B1 (it) * | 1993-07-09 | 1996-10-04 | Applied Pharma Res | Forme farmaceutiche destinate alla somministrazione orale in grado di rilasciare sostanze attive a velocita' controllata e differenziata |
| DE59408273D1 (de) * | 1993-09-07 | 1999-06-24 | Gergely Gerhard | Brausemischung mit Alkalisalzen oder Lysinaten saurer, unlöslicher oder schwer löslicher Wirkstoffe |
| US5458879A (en) * | 1994-03-03 | 1995-10-17 | The Procter & Gamble Company | Oral vehicle compositions |
| JPH10500982A (ja) | 1994-05-27 | 1998-01-27 | ファーマーク、ネダーランド、ベスローテン、フェンノートシャップ | 医薬組成物 |
| ZA959469B (en) * | 1994-11-15 | 1996-05-15 | South African Druggists Ltd | Pharmaceutical composition |
| IT1283029B1 (it) * | 1996-05-17 | 1998-04-03 | Resa Farma | Composizioni farmaceutiche a base di diclofenac |
| DE19538555A1 (de) | 1995-10-17 | 1997-04-24 | Beiersdorf Ag | Gegen Akne und entzündete Comedonen wirksame Wirkstoffkombinationen |
| ATE260646T1 (de) * | 1996-04-16 | 2004-03-15 | Novartis Consumer Health Sa | Schnell zerfallende orale dosierungsform |
| US7687542B2 (en) * | 1996-05-17 | 2010-03-30 | Kowa Pharmaeuticals America, Inc. | Rapidly bioavailable tablet and capsule formulations of diclofenac |
| US6974595B1 (en) | 1996-05-17 | 2005-12-13 | Proethic Pharmaceuticals, Inc. | Pharmaceutical compositions based on Diclofenae |
| US20060013896A1 (en) | 1996-05-17 | 2006-01-19 | Giorgio Reiner | Methods of treating acute pain using diclofenac |
| US5854279A (en) * | 1996-06-04 | 1998-12-29 | Eisai Co., Ltd | Therapeutic agent for dermatosis |
| US5914129A (en) | 1996-07-23 | 1999-06-22 | Mauskop; Alexander | Analgesic composition for treatment of migraine headaches |
| US6586458B1 (en) | 1996-08-16 | 2003-07-01 | Pozen Inc. | Methods of treating headaches using 5-HT agonists in combination with long-acting NSAIDs |
| US5788987A (en) | 1997-01-29 | 1998-08-04 | Poli Industria Chimica Spa | Methods for treating early morning pathologies |
| US6365180B1 (en) * | 1998-01-20 | 2002-04-02 | Glenn A. Meyer | Oral liquid compositions |
| EP1109534B1 (en) | 1998-09-10 | 2003-02-12 | Nycomed Danmark A/S | Quick release pharmaceutical compositions of drug substances |
| DK1312355T3 (da) * | 2001-11-20 | 2003-10-06 | Applied Pharma Res | Vandopløselige, ikke-brusende farmaceutiske præparater omfattende ikke-steroide antiinflammatoriske medikamenter |
| RU2202359C1 (ru) * | 2002-05-18 | 2003-04-20 | Агафонов Сергей Александрович | Лечебно-профилактическое средство |
| BRPI0409962A (pt) | 2003-05-08 | 2006-04-25 | Nektar Therapeutics Uk Ltd | co-formulação particulada de uma substáncia ativa e um excipiente, composição farmacêutica ou nutricêutrica, produto farmacêutico ou nutricêutico, método para preparar uma co-formulação particulada de uma substáncia ativa e um excipiente, e, uso de uma substáncia ativa e um excipiente |
| JO3352B1 (ar) * | 2005-06-17 | 2019-03-13 | Apr Applied Pharma Res Sa | صيغ دايكلوفيناك وطرق استخدامه |
| US7700125B2 (en) * | 2006-02-07 | 2010-04-20 | Kowa Pharmaceuticals America, Inc. | Moisture resistant container systems for rapidly bioavailable dosage forms |
| US7939561B2 (en) * | 2006-02-07 | 2011-05-10 | Apr Applied Pharma Research S.A. | Blister packaging for acute pain regimens |
-
2006
- 2006-06-11 JO JOP/2006/0177A patent/JO3352B1/ar active
- 2006-06-12 TW TW095120788A patent/TW200740470A/zh unknown
- 2006-06-16 EP EP06743167.6A patent/EP1890680B1/en active Active
- 2006-06-16 CN CN202011532717.2A patent/CN112755014A/zh active Pending
- 2006-06-16 PL PL06743167T patent/PL1890680T3/pl unknown
- 2006-06-16 GT GT200600261A patent/GT200600261A/es unknown
- 2006-06-16 ES ES13181615T patent/ES2717879T3/es active Active
- 2006-06-16 PT PT67431676T patent/PT1890680T/pt unknown
- 2006-06-16 EP EP11001797.7A patent/EP2402003B1/en active Active
- 2006-06-16 PE PE2006000678A patent/PE20070074A1/es not_active Application Discontinuation
- 2006-06-16 ES ES06743167.6T patent/ES2641889T3/es active Active
- 2006-06-16 AU AU2006257072A patent/AU2006257072B2/en not_active Ceased
- 2006-06-16 US US11/455,120 patent/US7759394B2/en active Active
- 2006-06-16 EP EP13181615.9A patent/EP2705837B1/en active Active
- 2006-06-16 NZ NZ564002A patent/NZ564002A/en not_active IP Right Cessation
- 2006-06-16 EP EP16157175.7A patent/EP3103441B1/en active Active
- 2006-06-16 CA CA2932603A patent/CA2932603C/en active Active
- 2006-06-16 CN CNA2006800296269A patent/CN101272768A/zh active Pending
- 2006-06-16 KR KR1020087001172A patent/KR101352130B1/ko not_active Expired - Fee Related
- 2006-06-16 MX MX2007016072A patent/MX2007016072A/es active IP Right Grant
- 2006-06-16 CN CN201510144782.0A patent/CN104856959A/zh active Pending
- 2006-06-16 WO PCT/EP2006/005799 patent/WO2006133954A2/en not_active Ceased
- 2006-06-16 CA CA2632375A patent/CA2632375C/en active Active
- 2006-06-16 ES ES16157175T patent/ES2912897T3/es active Active
- 2006-06-16 RU RU2008101784/15A patent/RU2432160C2/ru active
- 2006-06-16 TR TR2017/06038T patent/TR201706038T4/tr unknown
- 2006-06-16 BR BRPI0612245-0A patent/BRPI0612245A2/pt not_active Application Discontinuation
- 2006-06-20 AR ARP060102600A patent/AR057378A1/es unknown
-
2007
- 2007-12-07 EC EC2007007989A patent/ECSP077989A/es unknown
- 2007-12-13 ZA ZA200710858A patent/ZA200710858B/xx unknown
-
2008
- 2008-01-17 NO NO20080352A patent/NO342336B1/no unknown
-
2009
- 2009-03-06 US US12/399,175 patent/US20090197961A1/en not_active Abandoned
-
2010
- 2010-01-07 US US12/683,517 patent/US8097651B2/en active Active
-
2013
- 2013-01-16 US US13/742,871 patent/US8927604B2/en active Active
-
2014
- 2014-11-06 US US14/534,428 patent/US9827197B2/en active Active
-
2016
- 2016-02-22 HK HK16101926.9A patent/HK1213814A1/zh unknown
-
2017
- 2017-05-24 US US15/604,479 patent/US20170319484A1/en not_active Abandoned
-
2019
- 2019-12-17 US US16/716,511 patent/US20200323776A1/en not_active Abandoned
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200710858B (en) | Diclofenac formulations and methods of use | |
| IL184735A0 (en) | Pharmaceutical formulations and methods of use | |
| IL189602A0 (en) | Indenoisoquinolinone analogs and methods of use thereof | |
| IL186616A (en) | Spyro-oxa-indoles and their use as drugs | |
| IL191072A0 (en) | Therapeutic compositions and methods | |
| IL196956A0 (en) | Aza-benzofuranyl compounds and methods of use | |
| IL196462A0 (en) | Substituted acylanilides and methods of use thereof | |
| IL197185A0 (en) | Substituted acylanilides and methods of use thereof | |
| IL182734A0 (en) | 4-aminotetracyclines and methods of use thereof | |
| IL190885A0 (en) | Immunogenic compositions and methods of use | |
| IL197060A0 (en) | Aza-benzothiophenyl compounds and methods of use | |
| IL185309A0 (en) | Isoqunoline compounds and methods of use thereof | |
| IL194028A0 (en) | Tetrahydropyridothienopyrimidine compounds and methods of use thereof | |
| IL185723A0 (en) | Controlled release pharmaceutical compositions of liothyronine and methods of making and using the same | |
| PL2012805T3 (pl) | Kompozycja lecznicza i jej zastosowanie | |
| IL190583A0 (en) | Pth formulations and methods of use | |
| ZA200907727B (en) | Cinnamaldehyde formulations and methods of use | |
| ZA200900896B (en) | Aza-benzofuranyl compounds and methods of use | |
| PT1812072E (pt) | Formulações de benzotiazole e sua utilização | |
| PT1786431E (pt) | Formulações melhoradas de fotossensibilizador e o seu uso | |
| IL185575A0 (en) | Benzoxazocines and their therapeutic use | |
| IL186277A0 (en) | Dnt-maleate and methods of preparation thereof | |
| ZA200901009B (en) | Aza-benzothiophenyl compounds and methods of use | |
| EP1906950A4 (en) | ANSAMYCIN FORMULATIONS AND METHODS OF USE | |
| ZA200703998B (en) | Benzothiazole formulations and use thereof |